Significant others = 18 years of age, of patients who died of (chronic) diseases during the pandemic (March 2020-January 2023)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Significant others (= 18 years) of people who died of (chronic) diseases during the pandemic (March 2020-January 2023). People of all genders and ethnic backgrounds can participate in the study. Information material will be provided in German, Turkish, Polish, Russian, Arabic, French, and English. Professional interpreters will be involved in the qualitative data collection. The sample will consist of 15-25 significant others of patients without migration background and 5-10 significant others of patients with migration background. When choosing the participants, special attention will be paid to a heterogeneous sample selection. After receiving comprehensive verbal and written information about the type, content, purpose of the study, and study participation, significant others must sign a written informed consent form to participate in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: (1) Death by accident or suicide; (2) No informed consent due to cognitive impairment; (3) Withdrawal of consent to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be a qualitative overview of end-of-life care during the SARS-CoV-2 pandemic from the perspectives of significant others. The overview will include possible lasting consequences of the experience of dying under pandemic conditions for significant others and the extent to which they perceive connections between this experience and anxiety, depression, and complicated grief. The overview will be obtained by using qualitative interview data. The data will be analyzed following a qualitative content analysis. | — |
Countries
Germany
Contacts
Universitätsmedizin Göttingen, Klinik für Palliativmedizin